These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
885 related articles for article (PubMed ID: 7756034)
1. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection. Kronborg G APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034 [TBL] [Abstract][Full Text] [Related]
2. Lipopolysaccharide is present in immune complexes isolated from sputum in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection. Kronborg G; Shand GH; Fomsgaard A; Høiby N APMIS; 1992 Feb; 100(2):175-80. PubMed ID: 1554493 [TBL] [Abstract][Full Text] [Related]
3. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses. Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330 [TBL] [Abstract][Full Text] [Related]
4. Increased serum concentration of G-CSF in cystic fibrosis patients with chronic Pseudomonas aeruginosa pneumonia. Jensen PØ; Moser C; Kharazmi A; Presler T; Koch C; Høiby N J Cyst Fibros; 2006 Aug; 5(3):145-51. PubMed ID: 16503423 [TBL] [Abstract][Full Text] [Related]
5. Autoantibodies in serum and sputum from patients with cystic fibrosis. Schiøtz PO; Egeskjold EM; Høiby N; Permin H Acta Pathol Microbiol Scand C; 1979 Oct; 87(5):319-24. PubMed ID: 117671 [TBL] [Abstract][Full Text] [Related]
6. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle. Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750 [TBL] [Abstract][Full Text] [Related]
7. IgA and IgG antibodies against surface antigens of Pseudomonas aeruginosa in sputum and serum from patients with cystic fibrosis. Schiøtz PO; Høiby N; Permin H; Wiik A Acta Pathol Microbiol Scand C; 1979 Jun; 87C(3):229-33. PubMed ID: 113981 [TBL] [Abstract][Full Text] [Related]
8. Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis. Kolpen M; Hansen CR; Bjarnsholt T; Moser C; Christensen LD; van Gennip M; Ciofu O; Mandsberg L; Kharazmi A; Döring G; Givskov M; Høiby N; Jensen PØ Thorax; 2010 Jan; 65(1):57-62. PubMed ID: 19846469 [TBL] [Abstract][Full Text] [Related]
10. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response. Ciofu O APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154 [TBL] [Abstract][Full Text] [Related]
11. [Anti-Pseudomonas aeruginosa antibodies, circulating immune complexes, and anticytoplasm antibodies of neutrophils in patients with cystic fibrosis with and without Pseudomonas aeruginosa colonization]. Chiappini E; Taccetti G; Campana S; Turchini S; Marianelli L Pediatr Med Chir; 2001; 23(1):27-30. PubMed ID: 11486418 [TBL] [Abstract][Full Text] [Related]
12. Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis. Hartl D; Griese M; Kappler M; Zissel G; Reinhardt D; Rebhan C; Schendel DJ; Krauss-Etschmann S J Allergy Clin Immunol; 2006 Jan; 117(1):204-11. PubMed ID: 16387607 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of lipopolysaccharide-induced tumor necrosis factor secretion by hyperimmune serum from chronic infected patients. Kronborg G; Fomsgaard A; Høiby N Med Microbiol Immunol; 1993 Dec; 182(6):305-16. PubMed ID: 8121331 [TBL] [Abstract][Full Text] [Related]
16. Induction of oxidative burst response in human neutrophils by immune complexes made in vitro of lipopolysaccharide and hyperimmune serum from chronically infected patients. Kronborg G; Fomsgaard A; Jensen ET; Kharazmi A; Høiby N APMIS; 1993 Nov; 101(11):887-94. PubMed ID: 8286097 [TBL] [Abstract][Full Text] [Related]
17. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis. Pedersen SS APMIS Suppl; 1992; 28():1-79. PubMed ID: 1449848 [TBL] [Abstract][Full Text] [Related]
18. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients. Pier GB Behring Inst Mitt; 1997 Feb; (98):350-60. PubMed ID: 9382760 [TBL] [Abstract][Full Text] [Related]
19. Activated complement in the sputum from patients with cystic fibrosis. Schiøtz PO; Sørensen H; Høiby M Acta Pathol Microbiol Scand C; 1979 Feb; 87C(1):1-5. PubMed ID: 433601 [TBL] [Abstract][Full Text] [Related]
20. Immunology of Pseudomonas aeruginosa infection in cystic fibrosis. Høiby N; Pedersen SS; Jensen ET; Pressler T; Shand GH; Kharazmi A; Döring G Acta Univ Carol Med (Praha); 1990; 36(1-4):16-21. PubMed ID: 2130683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]